123 related articles for article (PubMed ID: 9243363)
1. Differential proliferation of endothelial cells and keratinocytes in psoriasis and spongiotic dermatitis.
Sweet WL; Smoller BR
J Cutan Pathol; 1997 Jul; 24(6):356-63. PubMed ID: 9243363
[TBL] [Abstract][Full Text] [Related]
2. Hsp72 antigen expression in the proliferative compartment of involved psoriatic epidermis.
Edwards MJ; Nazmi N; Mower C; Daniels A
J Cutan Pathol; 1999 Nov; 26(10):483-9. PubMed ID: 10599938
[TBL] [Abstract][Full Text] [Related]
3. Nature of cell kinetics in psoriatic epidermis.
Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
[TBL] [Abstract][Full Text] [Related]
4. A comparison of Ki-67 antigen presentation in acute generalized exanthematous pustulosis and pustular psoriasis.
Chang SL; Hu S; Hung SI; Huang YL; Hsiao WC; Chung WH
Arch Dermatol Res; 2010 Sep; 302(7):525-9. PubMed ID: 20336306
[TBL] [Abstract][Full Text] [Related]
5. Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers.
van Lingen RG; Poll MK; Seyger MM; de Jong EM; van de Kerkhof PC; van Erp PE
Arch Dermatol Res; 2008 Nov; 300(10):561-7. PubMed ID: 18496701
[TBL] [Abstract][Full Text] [Related]
6. Proliferative activity of CD8(+) T cells as an important clue to analyze T cell-mediated inflammatory dermatoses.
Deguchi M; Ohtani H; Sato E; Naito Y; Nagura H; Aiba S; Tagami H
Arch Dermatol Res; 2001 Sep; 293(9):442-7. PubMed ID: 11758786
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic overlap of psoriasis, eczema, and psoriasiform dermatoses: A retrospective study of T helper type 2 and 17 subsets, interleukin 36, and β-defensin 2 in spongiotic psoriasiform dermatitis, sebopsoriasis, and tumor necrosis factor α inhibitor-associated dermatitis.
Cohen JN; Bowman S; Laszik ZG; North JP
J Am Acad Dermatol; 2020 Feb; 82(2):430-439. PubMed ID: 31859047
[TBL] [Abstract][Full Text] [Related]
8. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro.
Leigh IM; Navsaria H; Purkis PE; McKay IA; Bowden PE; Riddle PN
Br J Dermatol; 1995 Oct; 133(4):501-11. PubMed ID: 7577575
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of GLUT-1 and Ki-67 in chronic plaque psoriasis.
Abdou AG; Maraee AH; Eltahmoudy M; El-Aziz RA
Am J Dermatopathol; 2013 Oct; 35(7):731-7. PubMed ID: 23392136
[TBL] [Abstract][Full Text] [Related]
10. Anti-proliferative and anti-inflammatory effects of 3β,6β,16β-Trihydroxylup-20(29)-ene on cutaneous inflammation.
Horinouchi CD; Mendes DA; Nolte S; Brito PS; Soley BD; Favero GM; Facundo VA; Santos AR; Cabrini DA; Otuki MF
J Ethnopharmacol; 2017 Jan; 195():298-308. PubMed ID: 27880883
[TBL] [Abstract][Full Text] [Related]
11. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin.
Wrone-Smith T; Mitra RS; Thompson CB; Jasty R; Castle VP; Nickoloff BJ
Am J Pathol; 1997 Nov; 151(5):1321-9. PubMed ID: 9358758
[TBL] [Abstract][Full Text] [Related]
12. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation.
Bruch-Gerharz D; Schnorr O; Suschek C; Beck KF; Pfeilschifter J; Ruzicka T; Kolb-Bachofen V
Am J Pathol; 2003 Jan; 162(1):203-11. PubMed ID: 12507903
[TBL] [Abstract][Full Text] [Related]
13. Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes.
Pincelli C; Fantini F; Romualdi P; Sevignani C; Lesa G; Benassi L; Giannetti A
J Invest Dermatol; 1992 Apr; 98(4):421-7. PubMed ID: 1372339
[TBL] [Abstract][Full Text] [Related]
14. Keratinocytes in inflammatory skin diseases.
Albanesi C; Scarponi C; Giustizieri ML; Girolomoni G
Curr Drug Targets Inflamm Allergy; 2005 Jun; 4(3):329-34. PubMed ID: 16101542
[TBL] [Abstract][Full Text] [Related]
15. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes.
Bruch-Gerharz D; Fehsel K; Suschek C; Michel G; Ruzicka T; Kolb-Bachofen V
J Exp Med; 1996 Nov; 184(5):2007-12. PubMed ID: 8920887
[TBL] [Abstract][Full Text] [Related]
16. Suppression of proliferation of human epidermal keratinocytes by 1,25-dihydroxyvitamin D3. Analysis of its effect on psoriatic lesion and of its mechanism using human keratinocytes in culture.
Kitano Y; Ikeda N; Okano M
Eur J Clin Invest; 1991 Feb; 21(1):53-8. PubMed ID: 1907555
[TBL] [Abstract][Full Text] [Related]
17. Dermal injection of immunocytes induces psoriasis.
Wrone-Smith T; Nickoloff BJ
J Clin Invest; 1996 Oct; 98(8):1878-87. PubMed ID: 8878440
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin expression in chronic plaque psoriasis: an association with the severity of disease.
Abdou AG; El Farargy S; Seleit I; Antar AG; Elhefny M; Elnaidany NF
Anal Quant Cytol Histol; 2012 Apr; 34(2):79-85. PubMed ID: 22611763
[TBL] [Abstract][Full Text] [Related]
19. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
20. Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis.
Shi HJ; Zhou H; Ma AL; Wang L; Gao Q; Zhang N; Song HB; Bo KP; Ma W
Br J Dermatol; 2019 Nov; 181(5):1028-1037. PubMed ID: 30822359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]